This finding likely reflects the dysfunctional angiogenic response characteristics of SSc, in which elevated VEGF fails to promote effective neovascularization due to endothelial damage and the concomitant increase in PAI-1, an anti-angiogenic mediator (41). The gene discussed is VEGFA; the disease is systemic sclerosis.